1. Home
  2. BJ vs UTHR Comparison

BJ vs UTHR Comparison

Compare BJ & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BJ
  • UTHR
  • Stock Information
  • Founded
  • BJ 1984
  • UTHR 1996
  • Country
  • BJ United States
  • UTHR United States
  • Employees
  • BJ N/A
  • UTHR N/A
  • Industry
  • BJ Department/Specialty Retail Stores
  • UTHR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BJ Consumer Discretionary
  • UTHR Health Care
  • Exchange
  • BJ Nasdaq
  • UTHR Nasdaq
  • Market Cap
  • BJ 12.3B
  • UTHR 20.7B
  • IPO Year
  • BJ 2018
  • UTHR 1999
  • Fundamental
  • Price
  • BJ $93.10
  • UTHR $460.55
  • Analyst Decision
  • BJ Buy
  • UTHR Buy
  • Analyst Count
  • BJ 17
  • UTHR 12
  • Target Price
  • BJ $115.13
  • UTHR $495.08
  • AVG Volume (30 Days)
  • BJ 1.7M
  • UTHR 582.6K
  • Earning Date
  • BJ 11-21-2025
  • UTHR 10-29-2025
  • Dividend Yield
  • BJ N/A
  • UTHR N/A
  • EPS Growth
  • BJ 9.79
  • UTHR 16.08
  • EPS
  • BJ 4.36
  • UTHR 26.38
  • Revenue
  • BJ $20,911,613,000.00
  • UTHR $3,128,400,000.00
  • Revenue This Year
  • BJ $8.09
  • UTHR $13.68
  • Revenue Next Year
  • BJ $6.34
  • UTHR $5.63
  • P/E Ratio
  • BJ $21.08
  • UTHR $17.37
  • Revenue Growth
  • BJ 2.48
  • UTHR 13.50
  • 52 Week Low
  • BJ $83.92
  • UTHR $266.98
  • 52 Week High
  • BJ $121.10
  • UTHR $479.50
  • Technical
  • Relative Strength Index (RSI)
  • BJ 52.99
  • UTHR 63.43
  • Support Level
  • BJ $87.17
  • UTHR $444.04
  • Resistance Level
  • BJ $92.53
  • UTHR $464.27
  • Average True Range (ATR)
  • BJ 2.42
  • UTHR 15.48
  • MACD
  • BJ 0.42
  • UTHR 1.15
  • Stochastic Oscillator
  • BJ 84.66
  • UTHR 71.34

About BJ BJ's Wholesale Club Holdings Inc.

BJ's Wholesale serves as one of the few warehouse club chains in the United States. Its 250 warehouses are primarily located along the East Coast, most prominently in the New England area. Similar to its warehouse club peers, BJ's charges annual membership fees and keeps costs down by operating a "no-frills" store environment. The company limits the use of distribution centers where possible and stores inventory on pallets directly on the sales floor, often in bulk quantities. The company also offers a limited assortment of 7,000 stock-keeping units at its warehouses to achieve greater procurement scale on select items. About 80% of BJ's net sales come from grocery items and general merchandise, with the remaining 20% stemming from gasoline and other ancillary services.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: